USFDA concludes inspection at Baddi facility of Panacea Biotec’s arm

13 Oct 2023 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection at Panacea Biotec’s material wholly-owned subsidiary -- Panacea Biotec Pharma (PBPL) at Baddi, Himachal Pradesh. The said facility has been inspected between October 03, 2023 and October 12, 2023. 

At the end of inspection, PBPL was issued a ‘FDA Form 483’ with nine observations which are related to improvements in existing procedures and are addressable. PBPL will respond to the USFDA within the stipulated time and work closely with USFDA to close the said observations.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

451.75 11.10 (2.52%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...